Site icon Health Sculpt

Difficult Constraints That Are Often Experienced By Patients With Bipolar Disorders And Skizophrene In Medical Services

Difficult Constraints That Are Often Experienced By Patients With Bipolar Disorders And Skizophrene In Medical Services

JAKARTA The public is advised not to delay consultation and therapy if they are aware of Bipolar Disorders (GB) and Skizophrenia, both in themselves, family and the surrounding environment. GB and Skizophrenia require proper and quick medical treatment, to prevent worsening of disease in patients. Consultation and therapy should be carried out immediately with a specialist in mental medicine (psychiatrist).

There are several obstacles that sometimes make it difficult for sufferers to get proper medical services according to their condition. This was conveyed by dr. Arwin Kandouw, Sp.KJ, Mental Medicine Specialist.

“Such as lack of understanding and lack of understanding, limited and difficult access to treatment (both health facilities and limited availability of drugs), or the reluctance of patients and families to seek treatment to a doctor,” he said in an official broadcast of PT Wellesta received by VOI.

In addition, he continued, there is also the denial of the patient and/or family that there is a medical condition that must immediately get help, a stigma of mental disorders that is still strong in the eyes of the community and the tendency of the community to seek alternative treatment first.

For this reason, he suggested, the arrangement of Skizophrenia and GB should be comprehensive. The most important thing is to improve brain chemical chaos through treatment, and involve people closest to the sufferer to support patients with good and regular treatment.

“The thing that needs to be considered is involving the government in providing treatment schemes, including financing them to be sustainable. In addition, in providing job opportunities that are in accordance with the capacity of patients,” he said.

Hanadi Setiarto, Country Group Head of Wellesta Indonesia stated, as a company focused on medical health and technology, Wellesta is committed to the health and quality of life of patients, including for GB andkizophrenia patients.

“It is very important to increase public knowledge and concern regarding mental illness conditions that are sometimes not realized. We realize that if it is not resolved properly, GB and Skizophrenia will continue to grow so that in the future it will reduce the quality of life, increase early mortality, and contribute to physical diseases such as cardiovascular, metabolic, and infection,” said Hanadi.

PT Wellesta Strengthens Commitment to Support Individuals with Bipolar and Skizophrene Disorders Through Education and Collaboration Programs, a leading pharmaceutical company in Indonesia, today reaffirms its commitment to improving the quality of life of people living with Bipolar Disorders (GB) and Schizophrene.

“We are trying to reduce stigma, increase public awareness, and provide better support for patients and their families through various educational programs and strategic cooperation. Overall handling is needed for bipolar disorder andappropriation, which is included in serious mental disorders,” he said.


The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language.
(system supported by DigitalSiber.id)


link

Exit mobile version